Laboratório de Micologia, Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Plataforma de Pesquisa Clínica, Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Mycoses. 2024 Sep;67(9):e13793. doi: 10.1111/myc.13793.
Sporotrichosis diagnosis involves a series of analyses, including culture and antibody detection in serum samples. Serologic methods may sometimes yield false-negative or false-positive results, leading to inaccurate diagnoses. This study assessed specific patient groups in which antibody detection of different isotypes and subclasses may lack sensitivity. An enzyme-linked immunosorbent assay (ELISA) with Sporothrix brasiliensis exoantigens was used to investigate IgM, IgG, IgG1, IgG2, IgG3, IgG4, IgA, IgA1 and IgA2 antibodies in human serum samples. Eighty serum samples from patients with different sporotrichosis clinical manifestations, including cutaneous forms with and without hypersensitivity manifestations, extracutaneous forms (bone, ocular, meningeal and pulmonary), disseminated cutaneous forms and disseminated forms in individuals living with HIV/AIDS, diabetics and alcoholics, were evaluated. The ELISA sensitivities in the detection of different antibodies ranged from 0.85 to 0.60 for the detection of IgG2 and IgG3, respectively. The antibodies with higher area under ROC curves were IgG2, IgG, IgA and IgA1. There were no significant differences in the immunological reactivity of the tested antibodies among different clinical forms of sporotrichosis. The data revealed a higher likelihood of a false-negative outcome in patients with lesions in the nasal mucosa regarding the detection of IgM and a lower likelihood in patients with lymphocutaneous sporotrichosis regarding the detection of IgG3. Patients with hypersensitivity manifestations had a 3.71 odds ratio to yield negative results in total IgG detection. In conclusion, we identified specific patient groups in which antibody detection may lack sensitivity, thus contributing to a better understanding of the diagnostic challenges associated with this condition.
孢子丝菌病的诊断涉及一系列分析,包括对血清样本进行培养和抗体检测。血清学方法有时可能会产生假阴性或假阳性结果,导致诊断不准确。本研究评估了不同同种型和亚类抗体检测可能缺乏敏感性的特定患者群体。使用巴西利什孢子丝菌外抗原的酶联免疫吸附试验(ELISA)检测人血清样本中的 IgM、IgG、IgG1、IgG2、IgG3、IgG4、IgA、IgA1 和 IgA2 抗体。评估了来自具有不同孢子丝菌临床表现的 80 例患者的血清样本,包括伴有和不伴有过敏表现的皮肤形式、皮肤外形式(骨、眼、脑膜和肺)、播散性皮肤形式和 HIV/AIDS、糖尿病和酗酒患者的播散性形式。不同抗体检测的 ELISA 敏感性范围为 IgG2 和 IgG3 的 0.85 至 0.60。ROC 曲线下面积较高的抗体为 IgG2、IgG、IgA 和 IgA1。不同孢子丝菌临床形式的测试抗体的免疫反应性没有差异。数据显示,鼻黏膜病变患者 IgM 检测的假阴性结果可能性更高,而淋巴管性孢子丝菌病患者 IgG3 检测的假阴性结果可能性更低。有过敏表现的患者在总 IgG 检测中出现阴性结果的可能性低 3.71 倍。总之,我们确定了特定的患者群体,在这些患者中,抗体检测可能缺乏敏感性,从而有助于更好地了解与这种情况相关的诊断挑战。